Revenue and Profitability - Revenue for Q1 2021 reached ¥191,740,938.17, representing a 107.72% increase compared to ¥92,308,286.63 in the same period last year[9] - Net profit attributable to shareholders was ¥40,468,120.27, a significant increase of 194.81% from ¥13,726,857.98 year-over-year[9] - Basic earnings per share rose to ¥0.08, up 166.67% from ¥0.03 in the previous year[9] - Operating revenue increased by 107.72% to ¥191,740,938.17 compared to ¥92,308,286.63, recovering from the impact of the pandemic[17] - The company expects a net profit attributable to shareholders of ¥60 million to ¥80 million, representing a growth of 804.80% to 1039.73% compared to the previous year[23] - Total operating revenue for Q1 2021 was 40,504,225.87 CNY, compared to 6,485,417.36 CNY in Q1 2020, representing a significant increase[41] - Net profit for Q1 2021 reached 40,022,420.82 CNY, up from 5,234,501.98 CNY in the same period last year, indicating a strong growth[41] - Earnings per share for Q1 2021 were 0.08 CNY, compared to 0.03 CNY in Q1 2020, reflecting improved profitability[42] Assets and Liabilities - Total assets increased by 24.05% to ¥1,848,638,388.51 from ¥1,490,246,817.08 at the end of the previous year[9] - Non-current assets totaled CNY 1,523,572,742.82, up from CNY 1,089,907,136.75 year-over-year, reflecting a growth of approximately 39.7%[34] - The company's total liabilities amounted to CNY 1,489,113,326.05, up from CNY 1,153,320,851.28, marking an increase of about 29.1%[33] - Current liabilities decreased to CNY 849,063,787.94 from CNY 887,144,143.63, showing a reduction of approximately 4.3%[33] - Long-term borrowings decreased by 69.23% to ¥80,000,000.00 from ¥260,000,000.00, primarily due to loan repayments[17] - Total assets reached CNY 2,419,806,438.78, with non-current assets accounting for CNY 2,311,987,100.11[59] - The company's equity attributable to shareholders was CNY 324,981,968.68, while total equity stood at CNY 336,925,965.80[57] Cash Flow - The net cash flow from operating activities was negative at -¥17,239,416.56, worsening by 107.02% compared to -¥8,327,515.78 in the previous year[9] - Cash and cash equivalents decreased by 39.43% to ¥91,351,330.55 from ¥150,810,281.63 due to repayment of bank loans[17] - The net cash flow from investing activities increased by 626.72% to ¥81,715,579.10 from ¥11,244,440.80, due to proceeds from the disposal of subsidiary equity[18] - The company reported a net cash outflow from financing activities of ¥93,890,862.00, a decrease of 525.52% compared to the previous year, also due to loan repayments[18] - Cash flow from operating activities for Q1 2021 was 205,533,057.78 CNY, compared to 148,760,613.82 CNY in Q1 2020, demonstrating strong cash generation[48] - The total cash and cash equivalents at the end of the period were 78,837,765.50 CNY, down from 269,831,175.11 CNY at the end of the previous year[50] Shareholder Information - The company had a total of 50,186 common shareholders at the end of the reporting period[13] - The largest shareholder, Guangzheng Investment Co., Ltd., held 25.01% of the shares, totaling 129,168,708 shares[13] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[14] - The company plans to repurchase up to 2 million shares at a price not exceeding ¥15 per share for future employee incentive plans[19] Expenses and Costs - Operating costs rose by 61.93% to ¥125,951,248.84 from ¥77,783,069.25, reflecting the increase in operating revenue[17] - Sales expenses surged by 216.21% to ¥48,890,770.46 from ¥15,461,643.25, driven by increased market activities and operational maintenance costs[17] - Research and development expenses for Q1 2021 amounted to 417,703.86 CNY, showing the company's commitment to innovation[41] Investment Performance - Investment income increased by 97.01% to ¥72,398,002.26 from ¥36,749,236.71 due to the sale of a subsidiary[18] - Investment income for Q1 2021 was 72,398,002.26 CNY, compared to 36,749,236.71 CNY in Q1 2020, indicating a positive trend in investment performance[41] Other Financial Metrics - The weighted average return on equity improved to 11.72%, up 10.19 percentage points from 1.53% in the same period last year[9] - Non-recurring gains and losses totaled ¥55,478,519.52, after accounting for tax impacts of ¥18,492,839.84[10] - The company reported a tax expense of 394,487.36 CNY for Q1 2021, up from 254,307.61 CNY in Q1 2020[41] - The company experienced a credit impairment loss of -678,119.13 CNY in Q1 2021, compared to -312,482.31 CNY in Q1 2020, indicating a need for monitoring credit risk[41]
光正眼科(002524) - 2021 Q1 - 季度财报